Clinical trialNCT00504829CompletedPhase 2Interventional

Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia

SponsorVeloxis PharmaceuticalsEnrollment220Dyslipidemia

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The current study is designed to test the efficacy, safety and tolerability of LCP-AtorFen, a combination of atorvastatin and fenofibrate.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Chivers Woodruff, Jr, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Cynthia Strout, MD
Coastal Carolina Research Center
Study Director
clinicaltrials.gov ↗
Dennis McCluskey, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Harry Geisberg, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
James Zavoral, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Jeff Geohas, MD
Radiant Research
Principal Investigator
clinicaltrials.gov ↗
Linda Murray, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Mark Kipnes, MD
Diabetes and Glandular Research Center, Inc.
Study DirectorKOL profile →
clinicaltrials.gov ↗
Michael Noss, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Michele Reynolds, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Randall Severance, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Stephen Halpern, MD
Radiant Research
Study Director
clinicaltrials.gov ↗
Timothy Howards, MD
Medical Affiliated Research Center, Inc.
Study Director
clinicaltrials.gov ↗
Wayne Larson, MD
Radiant Research
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Radiant Research, 515 N State Street, Suite 2700
Chicago, Illinois, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

LCP-AtorFenAtorvastatin →Fenofibrate →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jul 2007
Primary completion: 29 Feb 2008
Completion: 31 Jul 2008
Last update posted: 17 Feb 2020
Registered enrollment: 220
Registry id: NCT00504829

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.